CLDX Operating Income Growth
Celldex Therapeutics Inc · Operating Income Growth
CLDX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-38.81%period ending
CLDX TTM Operating Income YoY % (25.00% → -38.81%)
Year-over-year change
High-resolution chart · PNG
CLDX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| -38.8129% | |
| -42.3035% | |
| -47.3257% | |
| -37.2631% | |
| -33.5387% | |
| -33.52% | |
| -26.2298% | |
| -38.4852% | |
| -44.9739% | |
| -30.7205% | |
| -34.1115% | |
| -25.1753% | |
| -20.2744% | |
| -59.8335% | |
| -61.7478% | |
| -42.2877% | |
| -45.6851% | |
| -15.9906% | |
| -12.4505% | |
| -46.7797% | |
| -41.0415% | |
| -34.3696% | |
| -15.126% | |
| 4.8021% | |
| 2.0346% | |
| 8.6709% | |
| 64.822% | |
| 68.1088% | |
| 74.1884% | |
| 73.4585% | |
| -28.7253% | |
| -29.7945% | |
| -50.5505% | |
| -55.7492% | |
| 8.5679% | |
| 0.4928% | |
| 3.7302% | |
| 1.4449% | |
| -2.6054% | |
| -2.6125% | |
| -6.1487% | |
| -10.1211% | |
| -5.8065% | |
| -13.9199% | |
| -19.6384% | |
| -27.628% | |
| -50.3291% | |
| -48.2564% | |
| -56.5039% | |
| -53.6099% | |
| -40.2311% | |
| -625.4111% | |
| -837.2478% | |
| -1,637.1508% | |
| -116,254% | |
| -203.6284% | |
| -749.5272% | |
| -1,326.2948% | |
| 11.8167% | |
| 61.2573% | |
| 84.5123% | |
| 67.4889% | |
| 83.7506% | |
| 89.2495% | |
| 100% | |
| 74.1726% | |
| 68.0988% | |
| 56.436% | |
| -77.1784% | |
| -155.0991% | |
| -108.4781% | |
| -46.0657% | |
| 25.6483% | |
| -2,295.4323% | |
| -2,908.5829% | |
| -1,206.9906% | |
| 95.8611% | |
| 104.0996% | |
| 112.8624% | |
| 100% | |
| -45.2921% | |
| -59.3778% | |
| -62.9136% | |
| -15.7517% | |
| -1.7962% | |
| -3.2182% | |
| 20.2039% | |
| 18.6934% | |
| 30.788% | |
| 55.836% | |
| 48.7685% | |
| 41.2185% | |
| 20.6462% | |
| -18.4584% | |
| -45.0492% | |
| -59.0047% | |
| -59.9043% | |
| -62.6636% | |
| -45.3775% | |
| -29.2734% |